Chauvierre, C.; Aid-Launais, R.; Aerts, J.; Chaubet, F.; Maire, M.; Chollet, L.; Rolland, L.; Bonafé, R.; Rossi, S.; Bussi, S.;
et al. Pharmaceutical Development and Safety Evaluation of a GMP-Grade Fucoidan for Molecular Diagnosis of Cardiovascular Diseases. Mar. Drugs 2019, 17, 699.
https://doi.org/10.3390/md17120699
AMA Style
Chauvierre C, Aid-Launais R, Aerts J, Chaubet F, Maire M, Chollet L, Rolland L, Bonafé R, Rossi S, Bussi S,
et al. Pharmaceutical Development and Safety Evaluation of a GMP-Grade Fucoidan for Molecular Diagnosis of Cardiovascular Diseases. Marine Drugs. 2019; 17(12):699.
https://doi.org/10.3390/md17120699
Chicago/Turabian Style
Chauvierre, Cédric, Rachida Aid-Launais, Joël Aerts, Frédéric Chaubet, Murielle Maire, Lucas Chollet, Lydia Rolland, Roberta Bonafé, Silvia Rossi, Simona Bussi,
and et al. 2019. "Pharmaceutical Development and Safety Evaluation of a GMP-Grade Fucoidan for Molecular Diagnosis of Cardiovascular Diseases" Marine Drugs 17, no. 12: 699.
https://doi.org/10.3390/md17120699
APA Style
Chauvierre, C., Aid-Launais, R., Aerts, J., Chaubet, F., Maire, M., Chollet, L., Rolland, L., Bonafé, R., Rossi, S., Bussi, S., Cabella, C., Dézsi, L., Fülöp, T., Szebeni, J., Chahid, Y., Zheng, K. H., Stroes, E. S. G., Le Guludec, D., Rouzet, F.,
& Letourneur, D.
(2019). Pharmaceutical Development and Safety Evaluation of a GMP-Grade Fucoidan for Molecular Diagnosis of Cardiovascular Diseases. Marine Drugs, 17(12), 699.
https://doi.org/10.3390/md17120699